MDxHealth SA
MDxHealth SA is a Healthcare company operating in Diagnostics & Research with a $25.6M market cap.
Most recent earnings call: Q1 FY26 on May 13, 2026.
15 earnings calls indexed on Spoken Alpha.
Behavioral analysis
Disclosures
Extracted from SEC 10-K filing, 2026-06-21.
Transcripts
Most recent calls indexed for this ticker. Open any call to drill into prepared remarks and Q&A.
History
Reported quarters with consensus, surprise, and 1-day reaction context.
Spoken Alpha tracks MDXH's historical accountability: how often management beat consensus, how the stock reacted, and how guidance evolved across the cycle. The figures below are illustrative placeholder data generated for layout — they will be replaced with real deviation metrics, True Consensus values, and EODHD price reactions as those data layers land.
Beats consensus 5/10 quarters with 20% positive reaction rate
SamplePeers
Sector peers tracked by Spoken Alpha. Each links to the same machine-readable IR surface — earnings calls, executives, and accountability scores.
API
The same data on this page is available as a machine-readable feed via the Spoken Alpha API. One call returns the IR URL, recent transcripts, and accountability scores for MDXH.
$ curl https://api.spokenalpha.com/v1/companies/MDXHFAQ
Spoken Alpha indexes MDXH's earnings call transcripts at https://spokenalpha.com/companies/MDXH. Each call links to attributed speakers and parsed analyst Q&A. MDxHealth SA's own investor relations page is at https://investors.mdxhealth.com/financials/.
MDxHealth SA (MDXH) held its most recent earnings call on 2026-05-13, covering fiscal Q1 2026.
MDxHealth SA (MDXH) operates in the Healthcare sector (Diagnostics & Research industry).
Consistent execution against consensus with the stock following through is the cleanest signal a guidance regime is calibrated. Worth watching for the inflection where execution deteriorates relative to the bar.
Missed in 2 of the last 4 quarters
SampleRecent misses matter more than long-window beat rate — the trailing 12 months drives the analyst model and the next-print bar.
| Quarter | Actual EPS | Consensus | Surprise | 1D | 5D |
|---|---|---|---|---|---|
| Q1 FY2026 | $3.31 | $3.47 | -4.6% | -4.0% | -2.8% |
| Q4 FY2026 | $3.63 | $3.62 | +0.3% | +1.5% | +1.1% |
| Q3 FY2026 | $3.17 | $3.50 | -9.3% | -1.5% | -1.5% |
| Q2 FY2026 | $3.74 | $3.54 | +5.7% | +2.1% | +0.4% |
| Q1 FY2025 | $3.40 | $3.43 | -0.9% | -4.4% | -4.6% |
| Q4 FY2025 |
| $3.75 |
| $3.64 |
| +2.9% |
| -1.6% |
| -3.0% |
| Q3 FY2025 | $3.50 | $3.58 | -2.3% | -5.4% | -5.6% |
| Q2 FY2025 | $3.44 | $3.60 | -4.4% | -3.5% | -5.7% |
| Q1 FY2024 | $3.66 | $3.56 | +2.9% | -2.0% | -2.6% |
| Q4 FY2024 | $3.68 | $3.65 | +0.8% | -3.9% | -1.3% |